RETRACTED: MLPH Accelerates the Epithelial-Mesenchymal Transition in Prostate Cancer (Retracted Article)

被引:8
作者
Zhang, Tianbiao [1 ]
Sun, Yangyang [1 ]
Zheng, Tao [1 ]
Wang, Rui [1 ]
Jia, Donghui [1 ]
Zhang, Weixing [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou 450052, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2020年 / 13卷
关键词
MLPH; epithelial-to-mesenchymal transition; prostate cancer; beta-catenin; EMT;
D O I
10.2147/OTT.S225023
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction: Prostate cancer (PC) is the second greatest cause of cancer deaths globally. PC presents a poor prognosis once it metastasizes. There is considerable proof of vital epithelial-mesenchymal transition (EMT) functionality in PC metastasis. Previous studies revealed that melanophilin (MLPH) is associated with PC; however, its role in PC remains poorly understood. Methods: Bioinformatics analyses were performed. The cellular responses to MLPH knockdown were examined in HCC cell lines via wound healing assay, migration and invasion assay, Western blotting. Results: Analysis of the PROGgeneV2 database revealed that high MLPH expression might indicate poor overall survival. MLPH knockdown reduced PC cell migration, proliferation, and invasion. MLPH downregulation in vivo resulted in a lower growth rate and fewer metastatic nodules in lung tissues. Furthermore, MLPH knockdown recovered downregulated expression of the mesenchymal marker N-cadherin and the epithelial marker E-cadherin following a decrease in beta-catenin. Conclusion: These results indicate that progression of PC is stimulated via MLPH-dependent initiation of the EMT.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 26 条
[1]   PROSTATE CANCER [J].
Brody, Herb .
NATURE, 2015, 528 (7582) :S1-S1
[2]   Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites [J].
Bu, Huajie ;
Narisu, Narisu ;
Schlick, Bettina ;
Rainer, Johannes ;
Manke, Thomas ;
Schaefer, Georg ;
Pasqualini, Lorenza ;
Chines, Peter ;
Schweiger, Michal R. ;
Fuchsberger, Christian ;
Klocker, Helmut .
HUMAN MUTATION, 2016, 37 (01) :52-64
[3]   Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin [J].
Chen, Liping ;
Mai, Weiqian ;
Chen, Minfeng ;
Hu, Jianyang ;
Zhuo, Zhenjian ;
Lei, Xueping ;
Deng, Lijuan ;
Liu, Junshan ;
Yao, Nan ;
Huang, Maohua ;
Peng, Yinghui ;
Ye, Wencai ;
Zhang, Dongmei .
PHARMACOLOGICAL RESEARCH, 2017, 123 :130-142
[4]   Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer [J].
Chen, Wei-Yu ;
Tsai, Yuan-Chin ;
Yeh, Hsiu-Lien ;
Suau, Florent ;
Jiang, Kuo-Ching ;
Shao, Ai-Ning ;
Huang, Jiaoti ;
Liu, Yen-Nien .
SCIENCE SIGNALING, 2017, 10 (492)
[5]   Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer [J].
Cottard, Felicie ;
Madi-Berthelemy, Pauline Ould ;
Erdmann, Eva ;
Schaff-Wendling, Frederique ;
Keime, Celine ;
Ye, Tao ;
Kurtz, Jean-Emmanuel ;
Ceraline, Jocelyn .
ONCOTARGET, 2017, 8 (42) :72008-72020
[6]   Nerve Growth Factor Induces Proliferation and Aggressiveness in Prostate Cancer Cells [J].
Di Donato, Marzia ;
Cernera, Gustavo ;
Migliaccio, Antimo ;
Castoria, Gabriella .
CANCERS, 2019, 11 (06)
[7]   Role of epithelial to mesenchymal transition in hepatocellular carcinoma [J].
Giannelli, Gianluigi ;
Koudelkova, Petra ;
Dituri, Francesco ;
Mikulits, Wolfgang .
JOURNAL OF HEPATOLOGY, 2016, 65 (04) :798-808
[8]   PROGgeneV2: enhancements on the existing database [J].
Goswami, Chirayu Pankaj ;
Nakshatri, Harikrishna .
BMC CANCER, 2014, 14
[9]   New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy [J].
Haberkorn, Uwe ;
Eder, Matthias ;
Kopka, Klaus ;
Babich, John W. ;
Eisenhut, Michael .
CLINICAL CANCER RESEARCH, 2016, 22 (01) :9-15
[10]   A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells [J].
Huang, Xin ;
Zhu, Danyan ;
Lou, Yijia .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 564 (1-3) :26-36